✦ LIBER ✦

O63 EFFICACY AND SAFETY OF THE ALL-ORAL REGIMEN, MK-5172/MK-8742 +/− RBV FOR 12 WEEKS IN GT1 HCV/HIV CO-INFECTED PATIENTS: THE C-WORTHY STUDY

✍ Scribed by Sulkowski, M.; Mallolas, J.; Pol, S.; Bourliere, M.; Gerstoft, J.; Shibolet, O.; Nahass, R.; DeJesus, E.; Shaughnessy, M.; Hwang, P.; Wahl, J.; Robertson, M.N.; Haber, B.

Book ID: 122324312
Publisher: Elsevier Science
Year: 2014
Tongue: English
Weight: 60 KB
Volume: 60
Category: Article
ISSN: 0168-8278
DOI: 10.1016/S0168-8278(14)60065-9

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

O10 SAFETY AND EFFICACY OF THE ALL-ORAL

O10 SAFETY AND EFFICACY OF THE ALL-ORAL REGIMEN OF MK-5172/MK-8742 ± RIBAVIRIN IN TREATMENT-NAIVE, NON-CIRRHOTIC, PATIENTS WITH HEPATITIS C VIRUS GENOTYPE 1 INFECTION: THE C-WORTHY STUDY

✍ Hezode, C.; Serfaty, L.; Vierling, J.M.; Kugelmas, M.; Pearlman, B.; Sievert, W. 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 64 KB

O61 EFFICACY AND SAFETY OF MK-5172 AND M

O61 EFFICACY AND SAFETY OF MK-5172 AND MK-8742 ± RIBAVIRIN IN HEPATITIS C GENOTYPE 1 INFECTED PATIENTS WITH CIRRHOSIS OR PREVIOUS NULL-RESPONSE: THE C-WORTHY STUDY

✍ Lawitz, E.; Hezode, C.; Gane, E.; Tam, E.; Lagging, M.; Balart, L.; Rossaro, L.; 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 79 KB